+ND Capital — Full Portfolio

Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.

BiotechDeep TechSemiconductorsSouth San Francisco, US

Emily Marine Leproust(Executive Officer, Director, Promoter)William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Rob Chess(Director)

BoardKeith Crandell(Director)Paul Conley(Director)

PulseSight Therapeutics develops non-viral, plasmid-based gene therapies delivered via a proprietary electro-transfection system into the ciliary muscle to treat severe retinal diseases causing blindness.

BiotechHealthtechMedical Devices

BiotechSouth San Francisco, US

Cameron Wheeler(Director)Elaine Jones(Director)Wendye Robbins(Executive Officer, Director)William Slattery(Director)James Scopa(Director)

BoardLuke Evnin(Director)

Board seatPeter Van Vlasselaer· per SEC Form D · $50M raise · filed Oct 2019

BiotechNew York, US

David Darst(Chief Operating Officer)Shahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)Isabel Kurth(Vice President - Research)Masoud Tavazoie(Chief Scientific Officer)

Board seatPeter Van Vlasselaer· per SEC Form D · $11M raise · filed Feb 2021

ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases.

BiotechHealthtechMedical Devices

Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer.

AI & Machine LearningBiotechHealthtechSan Francisco, US

Justin Farlow(Co-founder)Colin Farlow(Co-founder)

Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy.

BiotechLongevityWellness & FitnessLausanne, CH

Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.

BiotechHealthtech

Constructive develops synthetic biology technology using recoded genomes and engineered tRNAs to incorporate novel chemical building blocks into proteins, enabling new therapeutics, materials, and manufacturing applications.

BiotechDeep TechNew Materials

Crocus Technology, now part of Allegro MicroSystems, develops XtremeSense TMR (Tunnel Magnetoresistance) magnetic sensing technology used in integrated current and position sensor ICs.

H55 develops electric propulsion systems and battery technology for aviation, with its first application being a two-seat fully electric pilot training aircraft (the Bristell B23 Energic) powered by a 104 kW propulsion system.

CleantechHardwareMobility & Transportation

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.

AI & Machine LearningBiotechDeep TechHealthtech

Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)Daniel Blessing(Chief Scientific Officer (CSO) & Co-founder)Richard Law(Chief Business Officer (CBO))Eric Adam(Chief Operating Officer (COO))Jordan Shin(Chief Medical Officer (CMO))Jérôme Andries(Chief Financial Officer (CFO))

Lightcast develops Envisia, a next-generation platform for single-cell functional screening and analysis that enables researchers to study biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

AI & Machine LearningBiotechDeep Tech

Manus develops and manufactures bioalternatives—sustainable ingredients produced using engineered microbes and cell factories—for use in food, flavor, fragrance, and other consumer products.

BiotechCleantechAugusta, US

Richard Goldstein(Director)Ajikumar Parayil(Executive Officer, Director)Gregory Stephanopoulos(Director)

BoardJason Whaley(Director)Carsten Boers(Director)

Notify Therapeutics is developing a non-hormonal female fertility treatment that targets the hormone-independent phase of early ovarian follicle development, aimed at infertile women who do not respond to standard hormone therapy.

BiotechDigital HealthFemTech

BiotechEmeryville, US

Igor Khandros(Executive Officer, Director)

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US

Sri Kosuri(Co-founder)in

Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome.

BiotechDigital HealthHealthtechMedical DevicesCalifornia, US

Jeroen(Co-founder and President)Ivan Dimov(Executive Officer, Director)Nathaniel Fernhoff(Executive Officer, Director)

BoardAlex Kolicich(Director)Jonathan MacQuitty(Director)

SiMa.ai designs silicon and software to enable machine learning inference at the edge, deployed in industrial, automotive, and autonomous systems rather than cloud environments.

AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US

Krishna Rangasayee(Founder & CEO)in

Spark develops LE-UWB, a wireless technology that delivers ultra-low latency and high throughput for applications including gaming, audio, industrial IoT, and medical devices.

Deep TechHardwareIoT

Vandria develops first-in-class orally available small molecules targeting a novel metabolic pathway to improve mitochondrial function and reduce chronic inflammation for age-related and chronic diseases of the CNS, muscle, lung, and liver.

BiotechHealthtechLongevity

Visby Medical manufactures at-home PCR tests for sexually transmitted infections, providing FDA-authorized results in 30 minutes.

Digital HealthFemTechHealthtechMedical Devices